Uveal melanoma
Abstract
Introduction: Uveal melanoma is the most common intraocular cancer in adults, represents approximately 3 % to 5 % of all melanomas; with a peak incidence in men in the sixth decade of life.
Objective: To describe the clinical presentation, diagnosis and treatment of a patient with uveal melanoma.
Case report: A 39-year-old female patient, with a health history, who came to the consultation due to intense pain of twelve days of evolution located in the right eye, associated with loss of vision, pain with eye movements, asthenia and anorexy. Physical examination revealed severe palpebral edema, abundant mucopurulent secretions, marked 360-degree conjunctival chemosis, and cilio-conjunctival hyperemia in the right eye. Analytical and imaging studies were performed. When analyzing the results of the physical and complementary examination, the surgical intervention consisting of right orbital exenteration, sphenoidectomy and right transorbital ethmoidectomy was decided. With a satisfactory evolution, she was discharged from the hospital. Biopsy reported choroidal melanoma.
Conclusions: Choroidal melanoma is a rare ocular entity in young black women. Symptomatology is extremely variable with choroidal masses. It is important to know its characteristics, since these clinical effects serve as a reminder for ophthalmologists to include it in the differential diagnosis of other ocular pathologies.
DeCS: PARANEOPLASTIC SYNDROMES, OCULAR/diagnosis; PARANEOPLASTIC SYNDROMES, OCULAR/surgery; MELANOMA; CHOROID NEOPLASMS; EYE ENUCLEATION.
Downloads
References
1. Gajdzis M, Kaczmarek R, Gajdzis P. Novel Prognostic Immunohistochemical Markers in Uveal Melanoma-Literature Review. Cancers [Internet]. 2021 [citado 14 Ago 2022];13(16):4031. Disponible en: https://www.mdpi.com/2072-6694/13/16/4031
2. Nathan P, Hassel JC, Rutkowski P, Baurain JF, Butler MO, Schlaak M, et al. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med [Internet]. 2021 Sep [citado 14 Ago 2022];385(13):1196-206. Disponible en: http://diposit.ub.edu/dspace/bitstream/2445/180520/3/NEJM2021Nathan.pdf
3. Menéndez-Hernández YC, O’Relly-Noda D, Cutiño-Hernández K, Pérez-Gutiérrez Y, Ribot-Ruiz LA. Panoftalmitis: presentación atípica de un melanoma coroideo. Rev med electrón [Internet]. 2022 Ene-Feb [citado 14 Ago 2022];44(1). Disponible en: http://scielo.sld.cu/scielo.php?pid=S1684-18242022000100227&script=sci_arttext&tlng=pt
4. Tsukikawa M, Akinpelu B, Wangaryattawanich P, Scherpelz K, Stacey AW. Uveal melanoma incidentally diagnosed with neuroimaging, a case series of 3 patients. Radiol Case Rep [Internet]. 2022 Ene [citado 14 Ago 2022];17(1):54-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572855/
5. Souri Z, Wierenga APA, Kroes WGM, Van der Velden PA, Verdijk RM, Eikmans M, et al. LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma. Cancers [Internet]. 2021 Sep [citado 14 Ago 2022];13(17):4445. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430821/
6. Singh M, Durairaj P, Yeung J. Uveal Melanoma: A Review of the Literature. Rev Oncol Ther [Internet]. 2018 [citado 14 Ago 2022];6:87-104. Disponible en: https://link.springer.com/article/10.1007/s40487-018-0056-8
7. Campos Alvergue S. Melanoma Coroideo: Reporte de Caso. Oftálmica [Internet]. 2021 Abr [citado 14 Ago 2022];20:20-4. Disponible en: http://pp.centramerica.com/pp/bancofotos/328-40608.pdf
8. Branisteanu DC, Bogdanici AM, Branisteanu DE, Maranduca IA, Zemba M, Balta F, et al. Uveal melanoma diagnosis and current treatment options (Review). Rev Experimental and therapeutic medicine [Internet]. 2021 [citado 14 Ago 2022];22(6):[aprox. 8 p.]. Disponible en: https://www.spandidos-publications.com/10.3892/etm.2021.10863
9. Fallico M, Raciti G, Longo A, Reibaldi M, Bonfiglio V, Ruso A, et al. Current molecular and clinical insights into uveal melanoma (Review). Intern J Oncol [Internet]. 2021 [citado 14 Ago 2022];10. Disponible en: https://www.spandidos-publications.com/ijo/58/4/10
10. Alemán Pérez A, Peñate Santana H, Rodríguez González F, Álvarez González E, Ogando González R, Alonso Pons V, et al. Melanoma coroideo. Caso clínico. Arch Soc Canar Oftalmol [Internet]. 2022 [citado 14 Ago 2022];33:100-3. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8461815
11. Frattini Cuaranta V, Murcia Castillo Y, Clementti M, González Rota MC, Cazón P, Galmarini R. Desprendimiento de retina como signo de melanoma coroideo. Arch Argent Oftalmol [Internet]. 2022 [citado 14 Ago 2022];20(1). Disponible en: https://archivosoftalmologia.com.ar/index.php/revista/article/view/187
12. López-Martínez AL, Bautista-Hernández Y, Moreno-Páramo D. Melanoma coroideo: reporte de casos y experiencia del Hospital General de México. Gac Mex Oncol [Internet]. 2022 [citado 14 Ago 2022];21(Suppl):1-6. Disponible en: https://www.gamo-smeo.com/frame_eng.php?id=287

Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/